PDK4 and cancer: In addition, an involvement of miR-122 in stem-associated phenotypes was previously reported in HCCs, where it inhibited cancer stem cell (CSC) glycolysis through the direct targeting of PDK4 [36,37,38], suggesting that miR-122 is fundamental for metabolic reprogramming of HCC cells.